Follow the 소마젠 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 소마젠 has logged 30 public disclosures. The latest transaction was reported on 6 November 2025 (Other). Among the most active insiders: 서정선. Every trade is free.
30
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
소마젠 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the diagnosis and treatment of diseases.